Treatment of epithelial tumours;Therapie epithelialer tumoren

Aktuelle Dermatologie

Volumn 34, Issue 12, 2008, Pages 482-486

  Terhorst, D ^a   Stockfleth, Eggert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DICLOFENAC; DICLOFENAC HYALURONIC ACID; FLUOROURACIL; HYALURONIC ACID; IMIQUIMOD; METHOTREXATE; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; CELL TRANSFORMATION; CHEMOSURGERY; CRYOSURGERY; CURETTAGE; HUMAN; LOW LEVEL LASER THERAPY; PHOTODYNAMIC THERAPY; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

EID: 58149378523     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1077567     Document Type: Review

References (16)

1. Stockfleth E. Hautkrebs - ein Leitfaden für die Praxis. 2. Auflage. Bremen: UNI-MED, 2008
2. Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 723-729
3. Ulrich M, Stockfleth E, Roewert-Huber J, Astner S. Noninvasive diagnostic tools for nonmelanoma skin cancer. Br J Dermatol 2007; 157 (Suppl 2): 56-58. Review.
4. Telfer NR, Colver GB, Morton CA, British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48
5. Nordin P, Larkö O, Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery. Br J Dermatol 1997; 136: 180-183
6. Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, Ding L, Thissen MR. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-1236
7. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22
8. Ulrich C, Degen A, Patel MJ, Stokfleth E. Sunscreens in organ transplant patients. Nephrol Dial Transplant 2008; 23: 1805-1808
9. Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157 (Suppl 2): 34-40
10. Stockfleth E, Kerl H, Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16: 599-606
11. de Berker D, McGregor JM, Hughes BR, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-230. Erratum in: Br J Dermatol 2008; 158: 873
12. Rivers JK, Arlette J, Shear N et al. Topical treatment of actinic keratoses with 3,0% diclofenac in 2,5% hyaluronan gel. Br J Dermatol 2002; 146: 94-100
13. Wolf JR, Taylor JR, Tschen E. Topical 3% diclofenac in 2Æ 5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709-713
14. Stockfleth E, Sterry W, Carey-Yard M, Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol 2007; 157: 41-46
15. Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus Bowen. A description of the disease in 617 patients. Acta Derm Venereol 1988; 68: 236-239
16. Breuninger H, Sebastian G, Kortmann RD, Wolff K, Bootz F, Garbe C. [Brief guidelines: squamous cell carcinoma of the skin, lip and eyelids]. J Dtsch Dermatol Ges 2006; 4: 260-262